Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2014 Feb;22(1):50–56. doi: 10.1037/a0034518

Table 1.

Characteristics of the sample by diagnosis group

All Gamblers
(n=1,507)
No Diagnosis
(n=829)
DSM-5 Only
(n=115)
Both Diagnoses
(n=563)
Test
Statistic*
p-value
Gender [males: n (%)] 1,150 (76.3) 609 (73.5)a 86 (74.8)a, b 455 (80.8)b 10.19 0.006
Race/Ethnicity [n (%)] 21.36 <0.0001
  African American 771 (51.2) 380 (45.8)a 63 (54.8)a, b 328 (58.3)b
  European American 543 (36.0) 341 (41.1)a 36 (31.3)b 166 (29.5)b
  Hispanic 98 (6.5) 62 (7.5) 5 (4.3) 31 (5.5)
  Other 95 (6.3) 46 (5.5) 11 (9.6) 38 (6.7)
Age (yr) [M (SD)] 41.3 (10.2) 41.0 (10.6) 41.3 (10.5) 41.7 (9.58) 1.48 0.478
  Range (Min – Max) 18–70 19–70 18–70 18–66
Education (yr) [M (SD)] 12.0 (1.96) 12.2 (2.04)a 11.9 (1.78)a, b 11.8 (1.86)b 17.51 <0.0001
SUDs (DSM-IV)
  Alcohol [n (%)] 1,306 (86.7) 703 (84.8)a 95 (82.6)a 508 (90.2)b 10.32 0.006
  Cocaine [n (%)] 1,219 (80.9) 636 (76.7)a 99 (86.1)b 484 (86.0)b 20.73 <0.0001
  Opioids [n (%)] 647 (42.9) 325 (39.2)a 48 (41.7)a, b 274 (48.7)b 12.33 0.002
  Cannabis [n (%)] 906 (60.1) 445 (53.7)a 70 (60.9)a, b 391 (69.4)b 34.81 <0.0001

Test value: Results from ANOVA for continuous data and Chi-square analysis for categorical data. When ANOVA showed a significant difference (p<0.05), the post-hoc Tukey-Kramer test was used to specify the group differences. Superscript labels with different letters reflect significant group differences. SUD=substance use disorder